Nifty200 Alpha30 News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Nifty200 Alpha30 from all sources in a single place.

Load latest

PB Fintech Ltd.

24 Apr 2025

1600.50

0.40%

Company Update

PB Fintech Ltd - 543390 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations & …

BSE India

Please find enclosed the intimation under Regulation 30 of SEBI (LODR) Regulations, 2015

pdf

Bharti Airtel Ltd.

24 Apr 2025

1820.50

0.18%

Airtel follows Vi, requests equity swap for pending spectrum dues

Business Standard

Officials say 2021 telecom reforms package allows the same, request to be studied

Bharti Airtel Ltd. has gained 37.29% in the last 1 Year

Solar Industries India Ltd.

24 Apr 2025

13135.00

2.96%

Company Update

Solar Industries India Ltd - 532725 - Announcement under Regulation 30 (LODR)-Credit Rating

BSE India

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosures) Requirements, 2015- Credit Rating

pdf

Persistent Systems Ltd.

24 Apr 2025

5273.00

-0.01%

Earnings Call

Persistent Systems Ltd - 533179 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

We wish to inform you that the Outcome and Audio call recording of the investor/analyst call held on Thursday, April 24, 2025, at 08:00 AM IST is available on the Company's website and the intimation of the same is as enclosed.

pdf

Persistent Systems Ltd.

24 Apr 2025

5273.00

-0.01%

Persistent Systems Q4 Results Review: PL Capital Upgrades The Stock To 'Buy' After Recent Correction

NDTV Profit

As the stock has witnessed sharp correction in recent times; PL Capital upgrades rating to Buy from earlier Accumulate while largely maintaining its target price.

Persistent Systems L.. has an average target of 5998.38 from 8 brokers.

Persistent Systems Q4 results: Profit rises 25% to 396 cr on strong growth

Business Standard | 24 Apr 2025 1 more

BSE Ltd.

24 Apr 2025

6522.50

3.47%

Regulations alone can't save you if you don't protect yourself: BSE CEO

Business Standard

Stressing the need for investor awareness and responsibility, BSE Managing Director and CEO Sundararaman Ramamurthy on Thursday said that regulations alone cannot protect investors if they do not take adequate precautions while investing. "You trade what you understand, and you understand what you trade if you don't do that, you have a problem," Ramamurthy said, urging investors to be vigilant and informed. He criticised the tendency of investors to rely on hearsay rather than due diligence. "You scan a vegetable before you buy it, but when you invest your life's earnings, you go by hearsay that's not how it should be," he said. On regulatory expectations, the BSE chief remarked that there is a general perception that regulators are blamed when investors lose money, but when markets do well the same person praise their own knowledge. "If you don't want to safeguard yourself, no amount of regulation can save you. Be alert," he stressed. Addressing the issue of retail participati

BSE Ltd. has gained 103.17% in the last 1 Year

Info Edge (India) Ltd.

24 Apr 2025

6951.50

-1.24%

AGM

Info Edge (India) Ltd - 532777 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

BSE India

Notice of Postal Ballot & Remote E-voting - Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015

pdf

Eternal Ltd.

24 Apr 2025

227.38

-0.62%

Zomato food delivery CEO Ranjan still part of leadership team: Eternal

Business Standard

Eternal, formerly Zomato, on Thursday clarified that its food delivery CEO Rakesh Ranjan has not resigned and that any reshuffling of the leadership team at the company is a standard practice as part of its efforts to optimize organizational effectiveness. The clarification through a regulatory filing came in response to a media report on the stepping down of Ranjan. "We would like to clarify as on date, there has been no resignation tendered by Rakesh Ranjan and he still continues to be part of the leadership team. At Eternal Group, internal reshuffling of the leadership team is considered a standard practice as part of the company's ongoing efforts to optimize organizational effectiveness," Eternal said. Earlier this month, the food and grocery delivery platform officially changed its name to 'Eternal Ltd' on the stock exchanges following approval from Ministry of Corporate Affairs. The brand name of the company's food delivery business, Zomato remains the same, along with the ap

Eternal Ltd. is trading above its 50 day SMA of 219.8

Zomato's food delivery CEO Rakesh Ranjan steps down amid internal reshuffle

Business Standard | 24 Apr 2025

InterGlobe Aviation Ltd.

24 Apr 2025

5358.50

0.85%

IndiGo Names Former FAA Administrator Michael Whitaker As Independent Director

NDTV Profit

Whitaker, also a private pilot, served most recently as the Administrator of the FAA, the US agency in charge of air safety, efficiency, and the operation of the national air traffic system.

InterGlobe Aviation Ltd. has gained 36.16% in the last 1 Year

IndiGo names ex-FAA administrator Michael Whitaker as independent director

Business Standard | 24 Apr 2025

Lupin Ltd.

24 Apr 2025

2106.60

4.31%

Lupin gets USFDA nod for generic kidney disease treatment drug Tolvaptan

Business Standard

Pharma major Lupin Ltd on Thursday said it has received approval from the US health regulator for its generic version of Tolvaptan tablets indicated for a certain type of kidney disease. The approval by the US Food and Drug Administration (USFDA) is for the abbreviated new drug application for Tolvaptan tablets of strengths 15 mg, 30 mg, 45 mg, 60 mg, and 90 mg, Lupin said in a regulatory filing. These are bioequivalent to Jynarque tablets in the same strengths of Otsuka Pharmaceutical Company Ltd, it added. "Lupin is the exclusive first-to-file for this product and is eligible for 180 days of generic drug exclusivity. This product will be manufactured at Lupin's Nagpur facility and will be launched soon," the company said. Commenting on the approval, Lupin CEO Vinita Gupta said,"This marks a significant entry into the nephrology segment and demonstrates our commitment to addressing the unmet needs of patients globally." Tolvaptan is indicated to slow kidney function decline in .

Lupin Ltd.'s price crossed above 200Day SMA today

Lupin gets USFDA nod for generic kidney disease treatment drug

Business Line | 24 Apr 2025

Nifty200 Alpha30 PB	6.2
Nifty200 Alpha30 PE	38.1
Nifty200 Alpha30 DIV	0.9
Nifty200 Alpha30 EPS	605.5